» Articles » PMID: 33468503

Altered Cytoskeletal Arrangement in Induced Pluripotent Stem Cells (iPSCs) and Motor Neurons from Patients with Riboflavin Transporter Deficiency

Overview
Journal Dis Model Mech
Specialty General Medicine
Date 2021 Jan 20
PMID 33468503
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

The cytoskeletal network plays a crucial role in differentiation, morphogenesis, function and homeostasis of the nervous tissue, so that alterations in any of its components may lead to neurodegenerative diseases. Riboflavin transporter deficiency (RTD), a childhood-onset disorder characterized by degeneration of motor neurons (MNs), is caused by biallelic mutations in genes encoding the human riboflavin (RF) transporters. In a patient- specific induced Pluripotent Stem Cells (iPSCs) model of RTD, we recently demonstrated altered cell-cell contacts, energy dysmetabolism and redox imbalance.The present study focusses on cytoskeletal composition and dynamics associated to RTD, utilizing patients' iPSCs and derived MNs. Abnormal expression and distribution of α- and β-tubulin (α- and β-TUB), as well as imbalanced tyrosination of α-TUB, accompanied by impaired ability to repolymerize after nocodazole treatment, were found in RTD patient-derived iPSCs. Following differentiation, MNs showed consistent changes in TUB content, which was associated with abnormal morphofunctional features, such as neurite length and Ca homeostasis, suggesting impaired differentiation.Beneficial effects of RF supplementation, alone or in combination with the antioxidant molecule N-acetyl-cystine (NAC), were assessed. RF administration resulted in partially improved cytoskeletal features in patients' iPSCs and MNs, suggesting that redundancy of transporters may rescue cell functionality in the presence of adequate concentrations of the vitamin. Moreover, supplementation with NAC was demonstrated to be effective in restoring all the considered parameters, when used in combination with RF, thus supporting the therapeutic use of both compounds.

Citing Articles

Modeling riboflavin transporter deficiency type 2: from iPSC-derived motoneurons to iPSC-derived astrocytes.

Magliocca V, Lanciotti A, Ambrosini E, Travaglini L, Dezio V, DOria V Front Cell Neurosci. 2024; 18:1440555.

PMID: 39113759 PMC: 11303166. DOI: 10.3389/fncel.2024.1440555.


Challenges and Efficacy of Astrocyte-to-Neuron Reprogramming in Spinal Cord Injury: In Vitro Insights and In Vivo Outcomes.

Niceforo A, Zholudeva L, Fernandes S, Shah Y, Lane M, Qiang L bioRxiv. 2024; .

PMID: 38585866 PMC: 10996511. DOI: 10.1101/2024.03.25.586619.


Caspase-dependent apoptosis in Riboflavin Transporter Deficiency iPSCs and derived motor neurons.

Marioli C, Muzzi M, Colasuonno F, Fiorucci C, Cicolani N, Petrini S Cell Death Discov. 2024; 10(1):54.

PMID: 38278809 PMC: 10817897. DOI: 10.1038/s41420-024-01812-y.


New Insights into the Neurodegeneration Mechanisms Underlying Riboflavin Transporter Deficiency (RTD): Involvement of Energy Dysmetabolism and Cytoskeletal Derangement.

Colasuonno F, Marioli C, Tartaglia M, Bertini E, Compagnucci C, Moreno S Biomedicines. 2022; 10(6).

PMID: 35740351 PMC: 9219947. DOI: 10.3390/biomedicines10061329.


Mitochondrial Abnormalities in Induced Pluripotent Stem Cells-Derived Motor Neurons from Patients with Riboflavin Transporter Deficiency.

Colasuonno F, Bertini E, Tartaglia M, Compagnucci C, Moreno S Antioxidants (Basel). 2020; 9(12).

PMID: 33317017 PMC: 7763948. DOI: 10.3390/antiox9121252.


References
1.
BRUCHER J, Dom R, Lombaert A, Carton H . Progressive pontobulbar palsy with deafness: clinical and pathological study of two cases. Arch Neurol. 1981; 38(3):186-90. DOI: 10.1001/archneur.1981.00510030080012. View

2.
OCallaghan B, Bosch A, Houlden H . An update on the genetics, clinical presentation, and pathomechanisms of human riboflavin transporter deficiency. J Inherit Metab Dis. 2019; 42(4):598-607. DOI: 10.1002/jimd.12053. View

3.
Goncalves F, Freddi T, Taranath A, Lakshmanan R, Goetti R, Feltrin F . Tubulinopathies. Top Magn Reson Imaging. 2018; 27(6):395-408. DOI: 10.1097/RMR.0000000000000188. View

4.
Romero F, MONSALVE E, Hermenegildo C, Puertas F, Higueras V, Nies E . Oxygen toxicity in the nervous tissue: comparison of the antioxidant defense of rat brain and sciatic nerve. Neurochem Res. 1991; 16(2):157-61. DOI: 10.1007/BF00965704. View

5.
Neuhaus A, Eggeling C, Erdmann R, Schliebs W . Why do peroxisomes associate with the cytoskeleton?. Biochim Biophys Acta. 2015; 1863(5):1019-26. DOI: 10.1016/j.bbamcr.2015.11.022. View